213 related articles for article (PubMed ID: 11390554)
1. Therapy of metastatic bone pain.
Serafini AN
J Nucl Med; 2001 Jun; 42(6):895-906. PubMed ID: 11390554
[TBL] [Abstract][Full Text] [Related]
2. Systemic metabolic radiopharmaceutical therapy in the treatment of metastatic bone pain.
Paes FM; Serafini AN
Semin Nucl Med; 2010 Mar; 40(2):89-104. PubMed ID: 20113678
[TBL] [Abstract][Full Text] [Related]
3. [Bone metastases treated with radiopharmaceuticals].
Giammarile F
Bull Cancer; 2013 Nov; 100(11):1223-7. PubMed ID: 24409472
[TBL] [Abstract][Full Text] [Related]
4. [Radionuclide therapy for painful bone metastases].
Szefer J; Zuchora Z
Wiad Lek; 2004; 57(5-6):280-3. PubMed ID: 15518077
[TBL] [Abstract][Full Text] [Related]
5. Radionuclides for metastatic bone pain palliation: a need for rational re-evaluation in the new millennium.
Krishnamurthy GT; Krishnamurthy S
J Nucl Med; 2000 Apr; 41(4):688-91. PubMed ID: 10768570
[No Abstract] [Full Text] [Related]
6. [Metabolic radiotherapy: what role will it have in 2001?].
George B; Douard MC; Rain JD
Cancer Radiother; 2002 May; 6(3):188-200. PubMed ID: 12116845
[TBL] [Abstract][Full Text] [Related]
7. Our experience on pain palliation of bone metastasis with Sr-89 or Sm-153 in cancer patients resistant to a conventional analgesic therapy. A retrospective study.
Montesano T; Giacomobono S; Acqualagna G; Colandrea M; Di Nicola A; Travascio L; Giancamerla M; D'Apollo R; Toteda M; Ugolini F; Filesi M; Ronga G
Clin Ter; 2009; 160(3):193-9. PubMed ID: 19756320
[TBL] [Abstract][Full Text] [Related]
8. Bone seeking radiopharmaceuticals for palliation of pain in cancer patients with osseous metastases.
Lam MG; de Klerk JM; van Rijk PP; Zonnenberg BA
Anticancer Agents Med Chem; 2007 Jul; 7(4):381-97. PubMed ID: 17630915
[TBL] [Abstract][Full Text] [Related]
9. Radiopharmaceuticals for the palliation of painful bone metastasis-a systemic review.
Bauman G; Charette M; Reid R; Sathya J
Radiother Oncol; 2005 Jun; 75(3):258-70. PubMed ID: 16299924
[TBL] [Abstract][Full Text] [Related]
10. The use of radioisotopes for palliation of metastatic bone pain.
Gkialas I; Iordanidou L; Galanakis I; Giannopoulos S
J BUON; 2008; 13(2):177-83. PubMed ID: 18555462
[TBL] [Abstract][Full Text] [Related]
11. Radionuclide therapy and integrated protocols for bone metastases.
Chiacchio S; Mazzarri S; Lorenzoni A; Nyakale N; Boni G; Borsò E; Alsharif A; Grosso M; Manca G; Greco C; Volterrani D; Mariani G
Q J Nucl Med Mol Imaging; 2011 Aug; 55(4):431-47. PubMed ID: 21738116
[TBL] [Abstract][Full Text] [Related]
12. Strontium 89 therapy for the palliation of pain due to osseous metastases.
Robinson RG; Preston DF; Schiefelbein M; Baxter KG
JAMA; 1995 Aug; 274(5):420-4. PubMed ID: 7542352
[TBL] [Abstract][Full Text] [Related]
13. State of the art of palliative therapy.
Seregni E; Padovano B; Coliva A; Zecca E; Bombardieri E
Q J Nucl Med Mol Imaging; 2011 Aug; 55(4):411-9. PubMed ID: 21738114
[TBL] [Abstract][Full Text] [Related]
14. Practice guideline for the performance of therapy with unsealed radiopharmaceutical sources.
Dillehay GL; Ellerbroek NA; Balon H; Brill DR; Grigsby PW; Macklis RM; Mauch PM; Mian TA; Potters L; Silberstein EB; Williams TR; Wong JC; Gaspar LE;
Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1299-307. PubMed ID: 16472933
[No Abstract] [Full Text] [Related]
15. Unsealed source therapy of painful bone metastases: an update.
McEwan AJ
Semin Nucl Med; 1997 Apr; 27(2):165-82. PubMed ID: 9144858
[TBL] [Abstract][Full Text] [Related]
16. Treatment of bone metastases of prostate cancer with strontium-89 chloride: efficacy in relation to the degree of bone involvement.
Kraeber-Bodéré F; Campion L; Rousseau C; Bourdin S; Chatal JF; Resche I
Eur J Nucl Med; 2000 Oct; 27(10):1487-93. PubMed ID: 11083537
[TBL] [Abstract][Full Text] [Related]
17. Systemic administration of new therapeutic radioisotopes, including phosphorus, strontium, samarium, and rhenium.
Porter AT; Ben-Josef E; Davis L
Curr Opin Oncol; 1994 Nov; 6(6):607-10. PubMed ID: 7827173
[TBL] [Abstract][Full Text] [Related]
18. Radiometabolic treatment of bone-metastasizing cancer: from 186rhenium to 223radium.
Rubini G; Nicoletti A; Rubini D; Asabella AN
Cancer Biother Radiopharm; 2014 Feb; 29(1):1-11. PubMed ID: 24180669
[TBL] [Abstract][Full Text] [Related]
19. Prospective evaluation of samarium-153-EDTMP radionuclide treatment for bone metastases in patients with hormone-refractory prostate cancer.
Dolezal J; Vizda J; Odrazka K
Urol Int; 2007; 78(1):50-7. PubMed ID: 17192733
[TBL] [Abstract][Full Text] [Related]
20. Radiopharmaceuticals: when and how to use them to treat metastatic bone pain.
Paes FM; Ernani V; Hosein P; Serafini AN
J Support Oncol; 2011; 9(6):197-205. PubMed ID: 22055888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
